Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α-induced barrier dysfunction and pro-inflammatory signalling

Microbiology

Volumn 156, Issue 11, 2010, Pages 3288-3297

  Donato, Kevin A ^a,b   Gareau, Mélanie G ^a   Wang, Yu Jing Jenny ^a   Sherman, Philip M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROBIOTIC AGENT; PROTEIN ZO1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; ELECTRIC RESISTANCE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LACTOBACILLUS RHAMNOSUS; MONOLAYER CULTURE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; TIGHT JUNCTION;

CACO-2 CELLS; CHEMOKINE CCL11; CULTURE MEDIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-8; INTESTINAL MUCOSA; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

LACTOBACILLUS RHAMNOSUS;

EID: 78049506125     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.040139-0     Document Type: Article

References (43)

1. Ahrens, R., Waddell, A., Seidu, L., Blanchard, C., Carey, R., Forbes, E., Lampinen, M., Wilson, T., Cohen, E. & other authors (2008). Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol 181, 7390-7399.
2. Ait-Belgnaoui, A., Han, W., Lamine, F., Eutamene, H., Fioramonti, J., Bueno, L. & Theodorou, V. (2006). Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 55, 1090-1094.
3. Baldassarre, M. E., Laforgia, N., Fanelli, M., Laneve, A., Grosso, R. & Lifschitz, C. (2010). Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J Pediatr 156, 397-401.
4. Basuroy, S., Seth, A., Elias, B., Naren, A. P. & Rao, R. (2006). MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 393, 69-77.
5. Blanchard, C. & Rothenberg, M. E. (2009). Chemotactic factors associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am 29, 141-148.
6. Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C. A., Madara, J. L., Hopkins, A. M. & Nusrat, A. (2003). Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171, 6164-6172.
7. Chen, W., Paulus, B., Shu, D., Wilson, I. & Chadwick, V. (2001). Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 36, 515-520.
8. Choi, C. H., Kim, T. I., Lee, S. K., Yang, K. M. & Kim, W. H. (2008). Effect of Lactobacillus GG and conditioned media on IL-1β-induced IL-8 production in Caco-2 cells. Scand J Gastroenterol 43, 938-947.
9. Donato, K. A., Zareie, M., Jassem, A. N., Jandu, N., Alingary, N., Carusone, S. C., Johnson-Henry, K. C. & Sherman, P. M. (2008). Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions. Microb Pathog 45, 377-385.
10. Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-van Langen, M. & Madsen, K. L. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295, G1025-G1034.
11. Fish, S. M., Proujansky, R. & Reenstra, W. W. (1999). Synergistic effects of interferon γ and tumour necrosis factor a on T84 cell function. Gut 45, 191-198.
12. Johnson-Henry, K. C., Nadjafi, M., Avitzur, Y., Mitchell, D. J., Ngan, B. Y., Galindo-Mata, E., Jones, N. L. & Sherman, P. M. (2005). Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 191, 2106-2117.
13. Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A. & Sherman, P. M. (2007). Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157 :H7 adhesion to epithelial cells. Cell Microbiol 9, 356-367.
14. Johnson-Henry, K. C., Donato, K. A., Shen-Tu, G., Gordanpour, M. & Sherman, P. M. (2008). Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157 : H7-induced changes in epithelial barrier function. Infect Immun 76, 1340-1348.
15. BEGFP mice reveal the critical role of TLR/NF-κB signaling in commensal bacteria-induced colitis. J Immunol 178, 6522-6532.
16. Ko, J. S., Yang, H. R., Chang, J. Y. & Seo, J. K. (2007). Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-α. World J Gastroenterol 13, 1962-1965.
17. Lamine, F., Fioramonti, J., Bueno, L., Nepveu, F., Cauquil, E., Lobysheva, I., Eutamene, H. & Theodorou, V. (2004). Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats. Scand J Gastroenterol 39, 37-45.
18. Lopez, M., Li, N., Kataria, J., Russell, M. & Neu, J. (2008). Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. J Nutr 138, 2264-2268.
19. Ma, T. Y., Iwamoto, G. K., Hoa, N. T., Akotia, V., Pedram, A., Boivin, M. A. & Said, H. M. (2004). TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol 286, G367-G376.
20. Marano, C. W., Lewis, S. A., Garulacan, L. A., Soler, A. P. & Mullin, J. M. (1998). Tumor necrosis factor-α increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 161, 263-274.
21. McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. & Radford-Smith, G. (2009). Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15, 100-113.
22. Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C. & other authors (2007). Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561.
23. Neurath, M. F., Pettersson, S., Meyer zum Buschenfelde, K. H. & Strober, W. (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2, 998-1004.
24. Peterson, M. D. & Mooseker, M. S. (1992). Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102, 581-600.
25. Petrof, E. O., Claud, E. C., Sun, J., Abramova, T., Guo, Y., Waypa, T. S., He, S. M., Nakagawa, Y. & Chang, E. B. (2009). Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-κB pathways and inhibits proteasome function. Inflamm Bowel Dis 15, 1537-1547.
26. Qin, H., Zhang, Z., Hang, X. & Jiang, Y. (2009). L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 9, 63.
27. Resta-Lenert, S. & Barrett, K. E. (2006). Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130, 731-746.
28. Round, J. L. & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9, 313-323.
29. Seth, A., Yan, F., Polk, D. B. & Rao, R. K. (2008). Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294, G1060-G1069.
30. Spehlmann, M. E. & Eckmann, L. (2009). Nuclear factor-κB in intestinal protection and destruction. Curr Opin Gastroenterol 25, 92-99.
31. Stadnyk, A. W. (2002). Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16, 241-246.
32. Tanabe, S., Kinuta, Y. & Saito, Y. (2008). Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 22, 181-185.
33. Tao, Y., Drabik, K. A., Waypa, T. S., Musch, M. W., Alverdy, J. C., Schneewind, O., Chang, E. B. & Petrof, E. O. (2006). Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290, C1018-C1030.
34. Utech, M., Ivanov, A. I., Samarin, S. N., Bruewer, M., Turner, J. R., Mrsny, R. J., Parkos, C. A. & Nusrat, A. (2005). Mechanism of IFN-γ-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16, 5040-5052.
35. Vanderpool, C., Yan, F. & Polk, D. B. (2008). Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14, 1585-1596.
36. Van Itallie, C. M. & Anderson, J. M. (2006). Claudins and epithelial paracellular transport. Annu Rev Physiol 68, 403-429.
37. Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T. & Turner, J. R. (2005). Interferon-c and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by upregulating myosin light chain kinase expression. Am J Pathol 166, 409-419.
38. Wang, F., Schwarz, B. T., Graham, W. V., Wang, Y., Su, L., Clayburgh, D. R., Abraham, C. & Turner, J. R. (2006). IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131, 1153-1163.
39. Yan, F. & Polk, D. B. (2002). Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959-50965.
40. Yan, F. & Polk, D. B. (2010). Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 26, 95-101.
41. Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K. & Polk, D. B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575.
42. Zareie, M., Riff, J., Donato, K., McKay, D. M., Perdue, M. H., Soderholm, J. D., Karmali, M., Cohen, M. B., Hawkins, J. & Sherman, P. M. (2005). Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol 7, 1782-1797.
43. Zhang, L., Li, N., Caicedo, R. & Neu, J. (2005). Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells. J Nutr 135, 1752-1756.